INSIGHTS ON FACILITY DESIGN
-
![outsourcing]( "The Economics Of Biomanufacturing Strategies: Can You Afford Failure?")
The Economics Of Biomanufacturing Strategies: Can You Afford Failure?Prior to making critical strategy decisions, a small biotech company completed an economic evaluation of manufacturing options to ensure it was selecting the best fit for its drug development needs.
-
![Millipore]( "Making Data Work")
Making Data WorkWhat is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.
-
![When clean is critical]( "When Clean Is Critical—Understanding Parameters And Definitions Of Clean")
When Clean Is Critical—Understanding Parameters And Definitions Of CleanClean room environments necessitate high-quality materials and equipment that conform to a variety of specified standards. This white paper explains how clean parameters are defined and validated.
-
![MilliporeSigma]( "Flexible Manufacturing: Better, Faster Virus Production")
Flexible Manufacturing: Better, Faster Virus ProductionThe global vaccine market is growing due to population growth, emerging pathogens and pandemics. The increased demand has led to new vaccines, manufacturing facility projects and increasing investments. Using flexible manufacturing strategies can help meet this growing vaccine demand.
-
Automating Cell Therapy Manufacturing For GMP Compliance And Consistency
Exploring the use of automation in cell therapy and advanced therapeutic medicinal product manufacturing to improve safety, quality, and compliance is a key factor in advancing patient care.
-
Facility Intensification And Cost Reduction Using An Integrated Buffer Delivery Platform
Outsourcing or implementing a streamlined buffer preparation and management systems allows biomanufacturers to considerably reduce floor usage, labor and costs. In this webinar, we will explore the benefits of an Integrated Buffer Delivery Platform.
-
Moving Toward A Closed CAR T Cell Manufacturing Process
Challenges to overcome in the CAR T manufacturing process include lengthy production times (11 - 21 days), product variability associated with open handling steps, and high manufacturing costs. Here we examine and evaluate individual CAR T cell unit operations, commercial reagents, and equipment with process closure potential to develop an improved workflow and increased product consistency.
-
Your Strategy To Manufacture, No Longer A One-Size-Fits-All
The traditional method of big batch manufacturing must change as companies move away from the one-size-fits-all blockbuster model toward more innovative, targeted biologics that deliver better outcomes.
-
Guidelines To Bring Your Biologic To Market: Are You Prepared?
Are you up to the task of bringing a biologic drug to market? Do you have a strategy and plan for moving forward? Here we explore, from a biopharma process development and manufacturing perspective.
FACILITY DESIGN SOLUTIONS
-
Ibex™ Dedicate
As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.
-
GE Life Sciences Overview - Cell Processing
Helping your cell therapies succeed through our reach and resources.
-
![genderless-aseptiquik-l-series-connectors]( "Genderless AseptiQuik® L Series Connectors")
Genderless AseptiQuik® L Series ConnectorsGenderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
-
Genderless AseptiQuik® L Series Connectors Datasheet
Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.
-
Cleanroom PODs® with LifeAire Systems
PODs coupled with LifeAire Systems’ purification technology offers extreme cleanliness and stability of the air in G-CON‘s prefabricated cleanrooms. This is achieved with LifeAire’s proven and patented multi-stage filtration systems built within the POD, eliminating all toxic airborne pathogens within critical space environments on a single pass. LifeAire’s new, transformational and proven technology provides deliverables that exceed GMP metrics that have been recognized as toxic to living cell culture.
